在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Streptococcus pneumoniae 50S ribosomal protein L24 (rplX) CSB-YP537947FNA
CSB-EP537947FNA
CSB-BP537947FNA
CSB-MP537947FNA
CSB-EP537947FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L15 (rplO) CSB-YP537948FNA
CSB-EP537948FNA
CSB-BP537948FNA
CSB-MP537948FNA
CSB-EP537948FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S13 (rpsM) CSB-YP537949FNA
CSB-EP537949FNA
CSB-BP537949FNA
CSB-MP537949FNA
CSB-EP537949FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Phosphopantetheine adenylyltransferase (coaD) CSB-YP537950FNA
CSB-EP537950FNA
CSB-BP537950FNA
CSB-MP537950FNA
CSB-EP537950FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Proline--tRNA ligase (proS), partial CSB-YP537951FNA
CSB-EP537951FNA
CSB-BP537951FNA
CSB-MP537951FNA
CSB-EP537951FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UPF0371 protein SPH_0451 (SPH_0451) CSB-YP537952FNA
CSB-EP537952FNA
CSB-BP537952FNA
CSB-MP537952FNA
CSB-EP537952FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase (dapH) CSB-YP537953FNA
CSB-EP537953FNA
CSB-BP537953FNA
CSB-MP537953FNA
CSB-EP537953FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae MutS2 protein (mutS2), partial CSB-YP537954FNA
CSB-EP537954FNA
CSB-BP537954FNA
CSB-MP537954FNA
CSB-EP537954FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae N utilization substance protein B homolog (nusB) CSB-YP537955FNA
CSB-EP537955FNA
CSB-BP537955FNA
CSB-MP537955FNA
CSB-EP537955FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Glutamyl-tRNA (Gln) amidotransferase subunit A CSB-YP537956FNA
CSB-EP537956FNA
CSB-BP537956FNA
CSB-MP537956FNA
CSB-EP537956FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L32 (rpmF) CSB-YP537957FNA
CSB-EP537957FNA
CSB-BP537957FNA
CSB-MP537957FNA
CSB-EP537957FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L9 (rplI) CSB-YP537958FNA
CSB-EP537958FNA
CSB-BP537958FNA
CSB-MP537958FNA
CSB-EP537958FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Chaperone protein DnaK (dnaK), partial CSB-YP537959FNA
CSB-EP537959FNA
CSB-BP537959FNA
CSB-MP537959FNA
CSB-EP537959FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UvrABC system protein C (uvrC), partial CSB-YP537960FNA
CSB-EP537960FNA
CSB-BP537960FNA
CSB-MP537960FNA
CSB-EP537960FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Hydroxyethylthiazole kinase 1 (thiM1) CSB-YP537961FNA
CSB-EP537961FNA
CSB-BP537961FNA
CSB-MP537961FNA
CSB-EP537961FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae S-adenosylmethionine synthase (metK) CSB-YP537962FNA
CSB-EP537962FNA
CSB-BP537962FNA
CSB-MP537962FNA
CSB-EP537962FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 30S ribosomal protein S20 (rpsT) CSB-YP537963FNA
CSB-EP537963FNA
CSB-BP537963FNA
CSB-MP537963FNA
CSB-EP537963FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Probable tRNA sulfurtransferase (thiI) CSB-YP537964FNA
CSB-EP537964FNA
CSB-BP537964FNA
CSB-MP537964FNA
CSB-EP537964FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Initiation-control protein yabA (SPH_1045) CSB-YP537965FNA
CSB-EP537965FNA
CSB-BP537965FNA
CSB-MP537965FNA
CSB-EP537965FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae 50S ribosomal protein L35 (rpmI) CSB-YP537966FNA
CSB-EP537966FNA
CSB-BP537966FNA
CSB-MP537966FNA
CSB-EP537966FNA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.51tesewang.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>